Mondal Himel, Komarraju Satya Lakshmi, D Sathyanath, Muralidharan Shrikanth
Department of Physiology, All India Institute of Medical Sciences, Deoghar, Jharkhand - 814152, India.
Director, National Institute of Naturopathy, Ministry of Ayush, Government of India, Pune - 411001, India.
Bioinformation. 2025 Jan 31;21(1):30-34. doi: 10.6026/973206300210030. eCollection 2025.
A retrospective analysis of 2919 yoga-related clinical trials registered in the World Health Organization (WHO) International Clinical Trials Registry Platform database using the keyword "yoga" on 10 September 2024 is of interest. Most trials were interventional (97.81%) and registered in the Clinical Trials Registry of India (56.39%) and ClinicalTrials.gov (26.07%). The majority included both genders (69.29%), with a mean age range of 23.9±13.45 to 56.21±24.66 years, focusing on chronic diseases like obesity, diabetes, hypertension and mental health conditions such as anxiety and depression. There was a steady increase in registrations over the years, reflecting the growing global interest in yoga research. Thus, the use of yoga as a therapeutic tool to support its integration into healthcare systems is highlighted.
对2024年9月10日在世界卫生组织（WHO）国际临床试验注册平台数据库中使用关键词“瑜伽”注册的2919项与瑜伽相关的临床试验进行回顾性分析很有意义。大多数试验为干预性试验（97.81%），且在印度临床试验注册中心（56.39%）和美国国立医学图书馆临床试验数据库（ClinicalTrials.gov，26.07%）注册。大多数试验纳入了男女两性（69.29%），平均年龄范围为23.9±13.45岁至56.21±24.66岁，重点关注肥胖、糖尿病、高血压等慢性病以及焦虑和抑郁等心理健康状况。这些年注册数量稳步增加，反映出全球对瑜伽研究的兴趣日益浓厚。因此，强调了将瑜伽作为一种治疗工具以支持其融入医疗保健系统的做法。
